课题基金 / 基金详情

SYNTHESIS/ ACTIVITY OF N-AMINOTETRAHYDROPYRIDINES

SYNTHESIS/ ACTIVITY OF N-AMINOTETRAHYDROPYRIDINES
N-氨基四氢吡啶的合成/活性
批准号:
6478810
负责人:
KINFE KEN REDDA
金额:
$3.04万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-05 至 2005-04-30

项目摘要

项目成果

KINFE KEN REDDA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective is the design, synthesis and pharmacological evaluation of novel and medicinally important N-amino-1,2,3,6- tetrahydropyridine derivatives. We reported the synthesis of novel N- iminopyridium ylides using the method employed by Tamura and modified in our laboratory. Sodium borohydride reduction of the ylides afforded the stable N-amino-1, 2,3,6-tetrahydropyridines in good yields. We also recently reported preliminary pharmacological test results of a few tetrahydropyridines that exhibited analgesic and anti-inflammatory activities with no observed toxicity, even at very high dose levels. Our earlier work provides the basis for new and exciting studies so that a series of compounds related to the most active analogs could be prepared, and retested and the octanol-water partition coefficient determined. Once sufficient data are accumulated, the compounds prepared will be subjected to structure activity analysis to study the electronic, steric and lipophilic effects of substituents. The physical and pharmacologic data obtained in this study will then be used to design drugs with more beneficial biological activity. The primary focus of the pharmacological studies will be to develop and easily synthesize effective and safe non- steroidal anti-inflammatory agents for the treatment of rheumatic diseases, including rheumatoid arthritis, osteoarthritis, gout and rheumatic fever.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DRUG DISCOVERY CORE FACILITY (DDCF)
DRUG DISCOVERY CORE FACILITY (DDCF)
DRUG DISCOVERY CORE FACILITY (DDCF)
DDR SUBPROJ 4: SYNTHESIS OF N-AMINOTETRAHYDROPYRIDINES AS ANTICANCER
海外基金